HJ Science Launches HK$1.11 Billion Hong Kong IPO

MT Newswires Live
06/12

HJ Science (HKG:6132) launched its Hong Kong initial public offering on Friday, seeking to raise HK$1.11 billion.

The Chinese biotechnology company is offering 13.6 million H shares at an indicative price of HK$81.80 per share, according to a Hong Kong bourse filing.

The offering comprises around 1.4 million shares for Hong Kong investors and 12.2 million shares for international investors, subject to reallocation.

The IPO's allocation results are due June 22, ahead of the company's planned trading debut on June 23.

Net proceeds will be used primarily to advance the company's clinical research and development activities.

The company secured six cornerstone investors, including Foresight Fund, that committed to subscribe to $65 million worth of IPO shares.

Citic Securities is the sole coordinator of the IPO.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10